Oramed Pharmaceuticals (ORMP) Q1 2023 Earnings

11MayConfirmed
Aug 22
Nov 22
Jan 23
Q1 2023
-0.27
-0.21
-0.14
-0.08

Details

Expected EPS
-0.26
Actual EPS
-0.08
Surprise EPS
0.18
Surprise Percent
+69.23%

Description

Oramed Pharmaceuticals (ORMP) has reported earnings of -0.08 per share for Q1 2023.

0 Comments

Share your thoughts